Preliminary outcomes of allograft and hydroxyapatite as substitutes for autograft in anterior cervical discectomy and fusion with self-locking standalone cages
Journal of Orthopaedic Surgery and Research volume 16, Article number: 123 (2021)
To investigate the efficacy and safety of allograft and hydroxyapatite (HA) as substitutes for autograft in anterior cervical discectomy and fusion (ACDF).
In this study, 49 patients (80 segments) treated with ACDF were included and allocated into three groups [group A, autogenous iliac bone, n = 18; group B, allogeneic bone, n = 16; group C, HA, n = 15]. The clinical efficacy and fusion status were compared among each group. Complications were recorded in detail, and the Bazaz classification and Voice Handicap Index-10 (VHI-10) were used to detect dysphagia and dysphonia.
Patients exhibited similar clinical efficacy among the groups during the final follow-up. All patients in groups A and B achieved fusion compared to only 73.3% of patients in group C. Groups A and B had similar fusion score, both of which greater than that of group C. No cage subsidence was observed in group A; however, 6.3% of patients in group B and 53.3% in group C had cage subsidence. Two patients in group A (11.1%) had persistent pain at the donor site. One patient in group B had dysphagia and dysphonia (6.3%), while one patient in group C had dysphonia (6.7%).
In ACDF, the autogenous iliac bone was the most ideal bone graft. The allogeneic bone was an acceptable substitute but risked cage subsidence and dysphagia. HA had a much lower fusion rate and a high risk of cage subsidence. Better substitutes should be further explored for ACDF.
Cervical spondylopathy is one of the most common degenerative diseases. Anterior cervical discectomy and fusion (ACDF) is an effective and safe surgical treatment for this disorder. The autologous iliac bone was previously considered to be the most ideal bone graft in ACDF due to its osteogenic, osteoconductive, and osteoinductive properties.
However, autogenous bone graft possessed the disadvantages such as extra trauma and chronic pain at the donor site. Hence, exploring adequate substitutes for autogenous iliac bone remains an issue [1,2,3,4,5]. Commercially available substitutes for autogenous iliac bone could be divided into allograft (cancellous allografts, cortical allografts, demineralized bone matrix), xenograft, synthetic graft (calcium sulfate, calcium phosphate ceramics [hydroxyapatites, tricalcium phosphate, biphasic calcium phosphate], calcium phosphate cements, bioactive glass), and growth factor products (bone morphogenetic proteins [BMPs], platelet-rich plasma [PRP]) are widely used . In spinal fusion, xenograft has been scarcely reported and BMP is usually used in combination with other bone grafts. The allogeneic bone has been widely used in clinical practice as a bone graft substitute, though its efficacy and safety remain to be verified . Its most common concern is its stimulation of an immunologic response [8,9,10,11] as well as its subsequent adverse events, such as its ability to achieve fusion [12,13,14] and dysphagia . Allogeneic bone was also associated with the risk of transmitting diseases and possessed ethical issues. Hydroxyapatite (HA) was another common bone graft substitute, which is a natural mineral found in bones, estimated to account for 50% of bone mass . Due to its chemical similarity with natural bone as well as its good biocompatibility and osteoconduction , hydroxyapatite may serve as an ideal bone graft substitute. Several authors reported its success in spinal fusion [18,19,20] while some other studies held opposite opinion . A prospective randomized controlled study found that 89% of HA grafts had graft fragmentation and 50% of HA grafts had obvious graft subsidence in ACDF . Similarly, a prospective, matched, and controlled study had to be discontinued early due to a high rate of resorption in the Chitra-HA graft (0% fusion rate) .
This study directly compares the clinical outcomes and fusion status among patients with different bone grafts in ACDF to investigate the efficacy of allograft and hydroxyapatite as substitutes for autogenous iliac bone. Moreover, specific complications pertaining to treatment were also recorded to evaluate treatment safety. In this paper, the application of these three kinds of bone graft materials in ACDF surgery is directly compared with each other, which has never been seen in previous articles, if any, similar articles are rare.
Patients who received ACDF from January 2014 to December 2018 and had clinical and radiographical follow-up were included in this study (Table 1). The inclusion criteria were patients diagnosed with cervical spondylotic myelopathy (CSM), cervical spondylotic radiculopathy (CSR), or mixed cervical spondylosis (MCS) with radiographic findings consistent with their clinical manifestations. The exclusion criteria were acute cervical spine and spinal cord injury, severe osteoporosis, and history of previous cervical surgery. Every patient was aware of that the data (without identifying information) might be used and published for the purpose of research and signed an informed consent form at admission and this study was approved by the institutional review board in our hospital.
The VAS (visual analog scale) score, JOA (Japanese Orthopaedic Association), score and NDI (neck disability index) were assessed at admission and during the final follow-up. Patient satisfaction was evaluated using the Odom standard : excellent, no symptoms related to cervical disease and able to perform daily activities without limitations; good, moderate symptoms related to cervical disease and able to perform daily activities without significant limitations; satisfactory, slight improvement in symptoms related to cervical disease and significant limitations in daily activities; poor, no improvement in, or aggravation of, symptoms related to cervical disease and not able to perform daily activities (Table 1).
Dysphagia and dysphonia were investigated using the Bazaz score [25, 26] (Table 2) and Voice Handicap Index-10 (VHI-10)  (Table 3). Patients with scores of VHI-10 not less than 11 were diagnosed as having dysphonia.
Cervical X-ray films taken in the neutral position were performed at admission, postoperatively and during the follow-up. Cage subsidence was defined as bony penetration of the implant more than 3 mm into the superior and/or inferior endplates of the adjacent vertebral body . The fusion status was evaluated according to the principles (Figs. 1, 2, and 3) outlined by Brantigan et al.  (Table 4). The height of the operation segment (HOS) was measured on lateral X-ray films (Fig. 4). The fusion status is evaluated by Changsheng Yang and Wentao Zhuo together. Due to lack of tissue in the cervical spine, the fusion status could be clearly evaluated.
Following tracheal intubation and the administration of general anesthesia, the patient was positioned supine with the cervical spine mildly extended. An anterior cervical incision was done using the classic Robinson and Cloward anterior technique. A C-arm X-ray machine was used to locate the cervical segment of the lesion, and the corresponding intervertebral space was opened and completely decompressed. After the cartilage endplate was treated, an appropriate type of zero notch self-stability cervical fusion cage (ROI-C) was placed into the decompressed intervertebral space, fixed by double anchoring wings . Patients would wear the cervical for most of time when they got up for the first 2 weeks, and they wear it only when they are outdoors in the next 4–6 weeks. The duration of operation, intraoperative blood loss, and postoperative hospital stay was recorded (Table 1).
The preoperative VAS score, JOA score, and NDI score were respectively compared with corresponding scores during the final clinical follow-up using a paired sample T test. One-way ANOVA was used to compare the improvement of the VAS score, JOA score, and NDI score among the three groups during clinical follow-up, duration of operation, blood loss, HOS, and the Brantigan score. The LSD test was used in multiple comparisons, and the Welch correction and Dunnett’s T3 test were employed when there was uneven variance. The rate of clinical effect given by a remark of “excellent” or “good,” subsidence rate, and fusion rate were compared using the R × C chi-square test or the Fisher’s exact probability method. Risk factors of failed fusion were also predicted through univariable and multivariable binary logistic regression analysis. Statistical significance was set at p< 0.05, and the results are presented as the mean ± SD.
In total, 49 patients (80 segments) treated with ACDF were included and allocated into three groups [group A, autogenous iliac bone, n = 18; group B, allogeneic bone, n = 16; group C, HA, n = 15]. Accordingly, no significant differences in age, gender distribution, ratio of single-segment/two or three-segment fusion and length of hospital stay after operation were found. Groups A and B had longer operation times and more blood loss than that of group C. Since HA was introduced recently, group C had a much shorter clinical follow-up time; however, radiographical follow-up time was similar among all groups (Table 4).
All patients demonstrated significant improvement in terms of their VAS score, JOA score, and NDI, and no significant differences among the groups were noted. According to the Odom criteria, 77.8% of patients in group A, 50% in group B, and 66.7% in group C had a “good” or “excellent” outcome, without significant differences among the groups (Table 5).
Generally, no significant differences among groups in terms of HOS on admission, postoperatively or at the final radiological follow-up existed. However, 6.3% of patients in group B and 53.3% in group C suffered from cage subsidence, while cage subsidence was not evident in group A. All patients developed solid fusion in groups A and B; however, only 73.3% of patients in group C got it at the final radiological follow-up. Furthermore, the Brantigan scores in groups A and B were significantly better than that in group C (Table 6).
We performed univariable analyses and found that the usage of HA (OR [odds ratio] = 3.30, 95%CI [95% confidence interval] = 0.948–8.211, p < 0.001), female gender (OR = 2.24, 95%CI = − 0.083–7.149, p = 0.060), and diabetes (OR = 1.37, 95%CI = − 3.460–1.106, p = 0.242) were potential predictors of failed fusion. To further confirm the impact of HA on fusion, we included female gender and diabetes for adjustment in the multivariable analyses and found that usage of HA was still a predictor of failed fusion (OR = 3.13, 95%CI = 0.963–8.643, p = 0.007) (Table 7).
In group A, one patient had chronic pain and another had hyperalgesia at the donor site. A patient with single level ACDF in group B complained of dysphagia and was only able to tolerate semi-fluid food and was diagnosed to have “serious dysphagia” according to the Bazaz classification. This patient scored 18 points according to the VHI-10 score and was evaluated to be abnormal in terms of dysphonia. One more case of dysphonia was found in group C, having 13 points in theVHI-10 score.
Complete decompression is an important prerequisite for the recovery of neurological function in ACDF. In this study, all operations were performed by senior spinal surgeons in our center, and all patients had significantly better VAS, JOA, and NDI scores postoperatively. Another goal in ACDF is to achieve solid fusion so as to reconstruct spinal stability and provide structural support for nerve repair. The present study investigated the efficacy of allograft and hydroxyapatite as substitutes for autograft in ACDF with fusion status as the primary outcome.
The autogenous bone had been proven effective in cervical fusion. Park et al.  included 32 patients with double-segmental ACDF using autogenous bone. The fusion rate was found to be 28.1%, 68.8%, 93.8%, and 93.8% at 3, 6, 12, and 24 months, respectively. In the present study, during the final radiological follow-up of group A (10.2 ± 7.8 months), all patients with autograft developed solid fusion, and no cage sinking was observed. The clinical follow-up (45.4 ± 5.8 months) of the autogenous bone group was the longest among three groups, indicating that the autogenous bone group is able to maintain long-term clinical effects. However, the autologous iliac bone required an additional surgical incision and was associated with chronic pain at the donor site. Here, two patients developed chronic pain at the donor site.
The allogeneic bone was one of the most widely used bone graft substitutes. Ryu et al. conducted a prospective study  and found that the imaging fusion rate of allogeneic bone at 12 months following ACDF surgery was 100% with no cage displacement. However, the allogenic bone might need more time to reach solid fusion. A prospective study performed by Suchomel et al.  demonstrated that the fusion rate of the autogenous bone group was 64.9% and 89.2%, while that of the allogeneic bone group was 25% and 63.1% at the 3rd and 6th month after ACDF, respectively, although the fusion rate was similar at the 12th month (94.6% versus 85.5%). Park et al.  found that the average duration of confirmed fusion in the allograft and autograft groups was 13.6 months and 7.7 months, respectively. In the present study, during the final imaging follow-up of group B (9.5 ± 5.3 months), the fusion rate of allograft was found to be 100%, which was the same as that of group A, but it had a lower fusion quality than that of the autogenous bone group (Brantigan score 4.0 ± 0.7 versus 4.6 ± 0.8). One case of cage sinking was found in group B.
Another problem pertaining to allogeneic bone was due to its immunogenicity, which may result in complications like dysphagia as well as reduced solid fusion. Yue et al.  investigated 74 patients with cervical spondylosis who had received allogeneic bone grafting before an average of 7.2 years, focusing on dysphagia associated with surgery. At the final review, 26 patients (35.1%) still suffered from dysphagia, including 12 patients with moderate dysphagia (16.2%) and 1 patient with severe dysphagia (1.4%). Miller et al. found that the incidence of dysphagia in allograft fusion was 4.3%, compared to 0% in autograft fusion. Goz et al.  also observed a higher prevalence in dysphagia within the allograft group. Moreover, the allogeneic bone was determined to be similar to BMP and possesses the same incidence of dysphagia. In the present study, the only dysphagia occurred in a patient treated with single-level ACDF in the allogeneic bone group. So we speculated the dysphagia in our study might be related with usage of allograft. Studies with larger sample size were warranted to confirm this observation. Other problems in relation to allografts include the difficulty of complete sterilization, spread of disease [34, 35], and ethical issues of harvest.
Another type of substitute for the autogenous bone was the artificial bone. The breakage of HA grafts was a common complication in 25% of patients in the study by Falavigna et al., although positive clinical results were observed at the same time . In another prospective study, 89% of HA grafts were found to be ruptured, and 50% of HA grafts were observed to be sunken. Moreover, the further recruitment of clinical trial participants was terminated due to the high rate of graft fragmentation, and collapse was observed in subsequent radiological assessments . In the present study, during the final imaging follow-up of group C (7.8 ± 3.0 months), it was found that the fusion rate of HA was 73.3%, which was significantly lower than that of patients with autograft and allograft with a decreased fusion score (3.1 ± 1.1) and high sedimentation rate (53.3%). Multivariable analyses further confirmed this observation (OR = 3.13, 95%CI = 0.963–8.643, p = 0.007). Thus, HA may not be applicable to ACDF. The absorption of HA is slow and could not match osteogenesis , and the vascularization rate of HA as an implant is also slow . Other factors, such as manufacturing and porosity, may clearly influence the formation of the new blood vessels ; however, the present study inferred that HA should not be widely used in ACDF prior to further investigation.
This study had several limitations. First, it was a retrospective cohort study in a single-center with a small sample size. Second, the duration of follow-up was relatively short, although a radiological follow-up of approximately half a year is sufficient in judging bone graft fusion in patients . Another limitation was that bone mineral density (BMD) data were not available because patients who were to receive ACDF would not be prescribed BMD routinely in our center. However, we compared the age and distribution of gender and found that there was no significant difference, indicating acceptable clinical heterogeneity in another profile.
In ACDF, the autogenous iliac bone was the most ideal bone graft but had the disadvantage of pain in the donor site. Allogeneic bone was an acceptable substitute but had the risk of less solid fusion and dysphagia. HA had a much lower fusion rate and a high risk of cage subsidence. Better substitute remained to be explored for ACDF.
Availability of data and materials
All the data are included in the manuscript, and further data can be requested from the corresponding author upon reasonable request.
Anterior cervical discectomy and fusion
Cervical spondylotic myelopathy
Cervical spondylotic radiculopathy
Mixed cervical spondylosis
Visual analog scale
Japanese Orthopedic Association
Neck disability index
Voice Handicap Index-10
Height of the operation segment
Cowan JA, Dimick JB, Wainess R, Upchurch GR, Chandler WF, La Marca F. Changes in utilization of spinal fusionin the United States. Neurosurgery. 2006;59(1):15–20. https://doi.org/10.1227/01.neu.0000243276.09094.5f.
Bae HW, Kanim LE, Delamarter RB. Spinal fusion in the United States analysis of trends from 1998 to 2008. Spine (Phila Pa 1976). 2012;37(1):67–76. https://doi.org/10.1097/BRS.0b013e31820cccfb.
Jacobs W, Willems PC, van Limbeek J, Anderson PG, Pavlov P, Bartels R, Oner C. Systematic review of anterior interbody fusion techniques for single- and double-level cervical degenerative disc disease. Spine (Phila Pa 1976). 2011;36(14):E950–60. https://doi.org/10.1097/BRS.0b013e31821cbba5.
Fernyhough JC, Schimandle JJ, Weigel MC, Edwards CC, Levine AM. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine (Phila Pa 1976). 1992;17(12):1474–80 http://sci-hub.ren/10.1097/00007632-199212000-00006.
Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3(3):192–5 https://sci-hub.tw/10.1097/00005131-198909000-00002.
Wang W, Yeung KWK. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioactive Materials. 2017;2017V2N4:224–47. https://doi.org/10.1016/j.bioactmat.2017.05.007.
Tuchman A, Brodke DS, Youssef JA, Meisel HJ, Dettori JR, Park JB, Yoon ST, Wang JC. Autograft versus allograft for cervical spinal fusion: a systematic review. Global Spine J. 2017;7(1):59–70. https://doi.org/10.1055/s-0036-1580610.
Elves MW, Ford CH. A study of the humoral immune response to osteoarticular allografts in the sheep. Clin Exp Immunol. 1974;17(3):497–508 http://yz365.com/Archive/Volume/9a11a66e-fafa-4a83-a467-47f8faf2e2b5.
Stevenson S, Shaffer JW, Goldberg VM. The humoral response to vascular and nonvascular allografts of bone. Clin Orthop Relat Res. 1996;326:86–95 https://sci-hub.tw/10.1097/00003086-199605000-00011.
Ward WG, Gautreaux MD, Lippert DC, Boles C. Hla sensitization and allograft bone graft incorporation. Clin Orthop Relat Res. 2008;466(8):1837–48 https://sci-hub.tw/10.1007/s11999-008-0294-4.
Ward WG, Heise E, Boles C, Kiger D, Gautreaux M, Rushing J, Smith BP, Bullard D. Human leukocyte antigen sensitization after structural cortical allograft implantations. Clin Orthop Relat Res. 2005;435:31–5 https://sci-hub.tw/10.1097/01.blo.0000165848.43820.98.
Steelman TJ, Helgeson MD, Seavey JG, Gwinn DE. Is structural allograft superior to synthetic graft substitute in anterior cervical discectomy and fusion? Clin Spine Surg. 2018;31(7):274–7 https://sci-hub.se/10.1097/bsd.0000000000000637.
Shriver MF, Lewis DJ, Kshettry VR, Rosenbaum BP, Benzel EC, Mroz TE. Pseudoarthrosis rates in anterior cervical discectomy and fusion: a meta-analysis. Spine J. 2015;15(9):2016–27. https://doi.org/10.1016/j.spinee.2015.05.010.
Floyd T, Ohnmeiss D. A meta-analysis of autograft versus allograft in anterior cervical fusion. Eur Spine J. 2000;9(5):398–403. https://doi.org/10.1007/s005860000160.
Yue WM, Brodner W, Highland TR. Persistent swallowing and voice problems after anterior cervical discectomy and fusion with allograft and plating: a 5- to 11-year follow-up study. Eur Spine J. 2005;14(7):677–82. https://doi.org/10.1007/s00586-004-0849-3.
Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res. 1981;157:259–78 https://sci-hub.tw/10.1097/00003086-198106000-00037.
Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res. 2010;132:15–30 http://www.ijmr.org.in/temp/IndianJMedRes132115-3387622_092436.pdf.
Koyama T, Handa J. Porous hydroxyapatite ceramics for use in neurosurgical practice. Surg Neurol. 1986;25(1):71–3 https://sci-hub.tw/10.1016/0090-3019(86)90118-7.
Zadegan SA, Abedi A, Jazayeri SB, Bonaki HN, Vaccaro AR, Rahimi-Movaghar V. Clinical application of ceramics in anterior cervical discectomy and fusion: a review and update. Global Spine J. 2017;7(4):343–9 https://doi.org/10.1177/2192568217699201.
Hu B, Yang X, Hu Y, Lyu Q, Liu L, Zhu C, Zhou C, Song Y. The n-HA/PA66 cage versus the PEEK cage in anterior cervical fusion with single-level discectomy during 7 years of follow-up. World Neurosurg. 2019;123:e678–84 https://doi.org/10.1016/j.wneu.2018.11.251.
Stark JR, Hsieh J, Waller D. Bone graft substitutes in single- or double-level anterior cervical discectomy and fusion: a systematic review. Spine (Phila Pa 1976). 2019;44(10):E618–28. https://doi.org/10.1097/BRS.0000000000002925.
McConnell JR, Freeman BJ, Debnath UK, Grevitt MP, Prince HG, Webb JK. A prospective randomized comparison of coralline hydroxyapatite with autograft in cervical interbody fusion. Spine (Phila Pa 1976). 2003;28(4):317–23. https://doi.org/10.1097/01.BRS.0000048503.51956.E1.
Acharya NK, Kumar RJ, Varma HK, Menon VK. Hydroxyapatite-bioactive glass ceramic composite as stand-alone graft substitute for posterolateral fusion of lumbar spine: a prospective, matched, and controlled study. J Spinal Disord Tech. 2008;21(2):106–11 https://sci-hub.se/10.1097/bsd.0b013e31805fea1f.
Broekema AEH, Molenberg R, Kuijlen JMA, Groen RJM, Reneman MF, Soer R. The odom criteria: validated at last: a clinimetric evaluation in cervical spine surgery. J Bone Joint Surg Am. 2019;101(14):1301–8 https://sci-hub.se/10.2106/jbjs.18.00370.
Bazaz R, Lee MJ, Yoo JU. Incidence of dysphagia after anterior cervical spine surgery: a prospective study. Spine (Phila Pa 1976). 2002;27(22):2453–8 https://journals.lww.com/spinejournal/Abstract/2002/11150/Incidence_of_Dysphagia_After_Anterior_Cervical.7.aspx.
Rosenthal BD, Nair R, Hsu WK, Patel AA, Savage JW. Dysphagia and dysphonia assessment tools after anterior cervical spine surgery. Clin Spine Surg. 2016;29(9):363–7 https://sci-hub.tw/10.1097/bsd.0000000000000373.
Coric D, Nunley PD, Guyer RD, Musante D, Carmody CN, Gordon CR, Lauryssen C, Ohnmeiss DD, Boltes MO. Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up: clinical article. J Neurosurg Spine. 2011;15(4):348–58. https://doi.org/10.3171/2011.5.SPINE10769.
Brantigan JW, Steffee AD. A carbon fiber implant to aid interbody lumbar fusion. Two-year clinical results in the first 26 patients. Spine (Phila Pa 1976). 1993;18(14):2106–7 https://sci-hub.ren/10.1097/00007632-199310001-00030.
Rong Y, Luo Y, Liu W, Gong F, Tang P, Cai W. Clinical effects of the bridge-type ROI-C interbody fusion cage system in the treatment of cervical spondylosis with osteoporosis. Clin Interv Aging. 2018;13:2543–51. https://doi.org/10.2147/CIA.S182969.
Park JS, Park SJ, Lee CS, Chung SS, Park HJ. Is allograft a more reliable treatment option than autograft in 2-level anterior cervical discectomy and fusion with plate fixation? Medicine (Baltimore). 2019;98(32):e16621. https://doi.org/10.1097/MD.0000000000016621.
Ryu SI, Mitchell M, Kim DH. A prospective randomized study comparing a cervical carbon fiber cage to the Smith-Robinson technique with allograft and plating: up to 24 months follow-up. Eur Spine J. 2006;15(2):157–64. https://doi.org/10.1007/s00586-005-0951-1.
Suchomel P, Barsa P, Buchvald P, Svobodnik A, Vanickova E. Autologous versus allogenic bone grafts in instrumented anterior cervical discectomy and fusion: a prospective study with respect to bone union pattern. Eur Spine J. 2004;13(6):510–5. https://doi.org/10.1007/s00586-003-0667-z.
Goz V, Buser Z, D'Oro A, Wang C, Yoon ST, Park JB, Youssef JA, Meisel HJ, Wang JC, Brodke DS. Complications and risk factors using structural allograft versus synthetic cage: Analysis 17 783 anterior cervical discectomy and fusions using a National Registry. Global Spine J. 2019;9(4):388–92. https://doi.org/10.1177/2F2192568218797096.
Mroz TE, Joyce MJ, Lieberman IH, Steinmetz MP, Benzel EC, Wang JC. The use of allograft bone in spine surgery: is it safe? Spine J. 2009;9(4):303–8. https://doi.org/10.1016/j.spinee.2008.06.452.
Couture J, Cabana F. Irradiated allograft bone in spine surgery: to culture or not? A single center retrospective study. Spine (Phila Pa 1976). 2013;38(7):558–63 http://sci-hub.ren/10.1097/brs.0b013e3182761109.
FalavignaA RO, Volquind D, Teles AR. Anterior cervical interbody fusion with hydroxyapatite graft: clinical and radiological analysis of graft breakage. Spine (Phila Pa 1976). 2009;34(25):2769–74 https://sci-hub.ren/10.1097/brs.0b013e3181ac32f6.
Bellucci D, Sola A, Cannillo V. Hydroxyapatite and tricalcium phosphate composites with bioactive glass as second phase: state of the art and current applications. J Biomed Mater Res A. 2016;104(4):1030–56. https://doi.org/10.1002/jbm.a.35619.
Schieker M, Heiss C, Mutschler W. Bone substitutes. Unfallchirurg. 2008;111(8):613–9. https://doi.org/10.1007/s00113-008-1489-6.
Klenke FM, Liu Y, Yuan H, Hunziker EB, Siebenrock KA, Hofstetter W. Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A. 2008;85(3):777–86. https://doi.org/10.1002/jbm.a.31559.
This research does not receive any financial support from any agency or commercial organization
Ethics approval and consent to participate
This study does not requires ethical approval and informed consent
Consent for publication
All the authors declare no conflict of interest
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yang, C., Zhuo, W., Li, Q. et al. Preliminary outcomes of allograft and hydroxyapatite as substitutes for autograft in anterior cervical discectomy and fusion with self-locking standalone cages. J Orthop Surg Res 16, 123 (2021). https://doi.org/10.1186/s13018-021-02257-0
- Anterior cervical discectomy
- Bone graft